Nirsevimab for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and Infants

被引：0

作者：

不详

机构：

来源：

AUSTRALIAN PRESCRIBER | 2024年 / 47卷 / 03期

关键词：

Beyfortus; immunisation; nirsevimab; respiratory syncytial virus; RSV;

D O I：

10.18773/austprescr.2024.027

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Approved indication: prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants born during or entering their first RSV season, and children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season

引用

页码：102 / 103

页数：2

共 50 条

[1] Will nirsevimab be the holy grail for prevention of respiratory syncytial virus lower respiratory tract infections in infants?
Homaira, Nusrat
[J]. TRANSLATIONAL PEDIATRICS, 2024, 13 (03) : 525 - 529
[2] Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use
Matt Shirley
[J]. Drugs & Therapy Perspectives, 2023, 39 : 413 - 420
[3] Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use
Shirley, Matt
[J]. DRUGS & THERAPY PERSPECTIVES, 2023, 39 (12) : 413 - 420
[4] Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)
Bergeron, Harrison C.
Tripp, Ralph A.
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (01) : 23 - 29
[5] COST-EFFECTIVENESS OF NIRSEVIMAB AGAINST RESPIRATORY SYNCYTIAL VIRUS LOWER RESPIRATORY TRACT DISEASE (RSV LRTD) IN THE US BIRTH COHORT
Kieffer, A.
Sardesai, A.
Musci, R.
Beuvelet, M.
De Su, Tribaldos Causadias M.
Lee, J. K. H.
Rizzo, C.
Greenberg, M.
[J]. VALUE IN HEALTH, 2023, 26 (12) : S135 - S135
[6] Nirsevimab: Expansion of Respiratory Syncytial Virus Prevention Options in Neonates, Infants, and At-Risk Young Children
Fly, J. Hunter
Eiland, Lea S.
Stultz, Jeremy S.
[J]. ANNALS OF PHARMACOTHERAPY, 2024,
[7] Treatment and prevention of respiratory syncytial virus lower respiratory tract infection
Simoes, EAF
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (03) : S14 - S17
[8] Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: A randomized equivalence trial
Kneyber, Martin C. J.
van Woensel, Job B. M.
Uijtendaal, Esther
Uiterwaal, Cuno S. P. M.
Kimpen, Jan L. L.
[J]. PEDIATRIC PULMONOLOGY, 2008, 43 (02) : 142 - 149
[9] The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
Simoes, Eric A. F.
[J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (SUPPL 2): : S143 - S147
[10] Respiratory syncytial virus - associated lower respiratory tract infections in hospitalized infants
D'Elia, C
Siqueira, MM
Portes, SA
Sant'Anna, CC
[J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2005, 38 (01) : 7 - 10

← 1 2 3 4 5 →